Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate having a hemostatic agent and an active pharmaceutical ingredient selectively positioned on the substrate. Kits, systems and methods are disclosed.

Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate and a hemostatic agent. The substrate includes a first piece and a second piece that is joined with the first piece. The first piece includes the hemostatic agent and the second piece includes an active pharmaceutical ingredient. Kits, systems and methods are disclosed.

Abstract: Implementations of a needle loader and related methods are provided. The needle loader comprises a housing, a movable arm disposed within the housing, and a needle mount defined on the movable arm to releasably attach to an arced suturing needle. The needle loader further includes an arced needle releasably attached to the needle mount. The needle can be held in place on the needle mount by way of an interference fit. The needle mount can be defined on a surface of the movable arm that faces an arced needle track of a suturing device when loading an arced suturing needle in the needle track of the suturing device.

Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate and a hemostatic agent. The substrate includes a first piece and a second piece that is joined with the first piece. The first piece includes the hemostatic agent and the second piece includes an active pharmaceutical ingredient. Kits, systems and methods are disclosed.

Abstract: A respirator mask includes a facepiece configured to create a seal with a face of a user and a mask frame coupled with the facepiece. A port assembly is coupled with the mask frame and an inhalation path including a filter, a first valve seat and a first valve member, the filter and first valve member coupled with the first valve seat on opposed sides. An exhalation path includes a second valve seat and a second valve member, the second valve member surrounding the first valve seat.

Abstract: A stapler reload assembly includes a cartridge body defining a housing to receive staples. The cartridge body has a first side comprising a plurality of staple apertures configured to eject staples housed in the cartridge body. The cartridge body has a second side, opposite the first side, comprising a plurality of pusher apertures through which staple pushers of the cartridge body are accessible. A staple retainer is removably coupled to the first side of the cartridge body and at least partially covers the plurality of staple apertures. A cover is removably coupled to and at least partially covers the plurality of pusher apertures. Devices and methods relate to stapler reload assemblies.

Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate having a hemostatic agent and an active pharmaceutical ingredient selectively positioned on the substrate. Kits, systems and methods are disclosed.

Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate formed from a first material and a second material. At least one of the first and second materials includes a hemostatic agent. Kits, systems and methods are disclosed.

Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate having a hemostatic agent and an active pharmaceutical ingredient selectively positioned on the substrate. Kits, systems and methods are disclosed.

Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate and a hemostatic agent. The substrate includes a first piece and a second piece that is joined with the first piece. The first piece includes the hemostatic agent and the second piece includes an active pharmaceutical ingredient. Kits, systems and methods are disclosed.

Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate and a hemostatic agent. The substrate includes a first piece and a second piece that is joined with the first piece. The first piece includes the hemostatic agent and the second piece includes an active pharmaceutical ingredient. Kits, systems and methods are disclosed.

Abstract: A respirator mask includes a facepiece configured to create a seal with a face of a user and a mask frame coupled with the facepiece. A port assembly is coupled with the mask frame and an inhalation path including a filter, a first valve seat and a first valve member, the filter and first valve member coupled with the first valve seat on opposed sides. An exhalation path includes a second valve seat and a second valve member, the second valve member surrounding the first valve seat.

Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate and a hemostatic agent. The substrate includes a first piece and a second piece that is joined with the first piece. The first piece includes the hemostatic agent and the second piece includes an active pharmaceutical ingredient. Kits, systems and methods are disclosed.

Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate having a hemostatic agent and an active pharmaceutical ingredient selectively positioned on the substrate. Kits, systems and methods are disclosed.

Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate formed from a first material and a second material. At least one of the first and second materials includes a hemostatic agent. Kits, systems and methods are disclosed.